Gene · 5378
Papers1,886
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 1,886
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mixed responses to first-line alectinib in non-small cell lung cancer patients with rare ALK gene fusions: A case series and literature review. | J Cell Mol Med | 2021 | 34541785 | PubTator, text mining | PubMed |
| Genomic alteration profiles of lung cancer and their relationship to clinical features and prognosis value using individualized genetic testing. | J Thorac Dis | 2021 | 34527339 | PubTator, text mining | PubMed |
| Genomic and transcriptomic analyses reveal a tandem amplification unit of 11 genes and mutations in mismatch repair genes in methotrexate-resistant HT-29 cells. | Exp Mol Med | 2021 | 34521988 | PubTator, text mining | PubMed |
| MTHFR Knockdown Assists Cell Defense against Folate Depletion Induced Chromosome Segregation and Uracil Misincorporation in DNA. | Int J Mol Sci | 2021 | 34502300 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors. | World J Gastrointest Oncol | 2021 | 34457187 | PubTator, text mining | PubMed |
| Metabolism-associated genes in occurrence and development of gastrointestinal cancer: Latest progress and future prospect. | World J Gastrointest Oncol | 2021 | 34457185 | PubTator, text mining | PubMed |
| Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC). | Int J Mol Sci | 2021 | 34445631 | PubTator, text mining | PubMed |
| NGS Analysis Confirms Common TP53 and RB1 Mutations, and Suggests MYC Amplification in Ocular Adnexal Sebaceous Carcinomas. | Int J Mol Sci | 2021 | 34445161 | PubTator, text mining | PubMed |
| The Role of DNA Damage Response in Dysbiosis-Induced Colorectal Cancer. | Cells | 2021 | 34440703 | PubTator, text mining | PubMed |
Mitogen signal-associated pathways, energy metabolism regulation, and mediation of tumor immunogenicity play essential roles in the cellular response of malignant pleural mesotheliomas to platinum-based treatment: a retrospective study. | Transl Lung Cancer Res | 2021 | 34430345 | PubTator, text mining | PubMed |
| [Genetic analysis of 45 patients with suspected Lynch syndrome using next-generation sequencing]. | Zhonghua Zhong Liu Za Zhi | 2021 | 34407589 | PubTator, text mining | PubMed |
| Mutations of p53 associated with pancreatic cancer and therapeutic implications. | Ann Hepatobiliary Pancreat Surg | 2021 | 34402431 | PubTator, text mining | PubMed |
| Handcuffing intrinsically disordered regions in Mlh1-Pms1 disrupts mismatch repair. | Nucleic Acids Res | 2021 | 34390347 | PubTator, text mining | PubMed |
| Crosstalk between autophagy and DNA repair systems. | Turk J Biol | 2021 | 34377049 | PubTator, text mining | PubMed |
| A novel human endometrial epithelial cell line for modeling gynecological diseases and for drug screening. | Lab Invest | 2021 | 34376780 | PubTator, text mining | PubMed |
| Unusual immunohistochemical "null" pattern of four mismatch repair proteins in gastric cancer: A case report. | World J Clin Cases | 2021 | 34368332 | PubTator, text mining | PubMed |
| FAN1-MLH1 interaction affects repair of DNA interstrand cross-links and slipped-CAG/CTG repeats. | Sci Adv | 2021 | 34330701 | PubTator, text mining | PubMed |
| Colorectal Cancer: From Genetic Landscape to Targeted Therapy. | J Oncol | 2021 | 34326875 | PubTator, text mining | PubMed |
| Analysis of Sequence and Copy Number Variants in Canadian Patient Cohort With Familial Cancer Syndromes Using a Unique Next Generation Sequencing Based Approach. | Front Genet | 2021 | 34326862 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5378/papers?page=24